Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

被引：47
|
作者：
Porat, Yaara [1 ]
Giladi, Moshe [1 ]
Schneiderman, Rosa S. [1 ]
Blat, Roni [1 ]
Shteingauz, Anna [1 ]
Zeevi, Einav [1 ]
Munster, Mijal [1 ]
Voloshin, Tali [1 ]
Kaynan, Noa [1 ]
Tal, Orna [1 ]
Kirson, Eilon D. [2 ]
Weinberg, Uri [3 ]
Palti, Yoram [2 ]
机构：
[1] Novocure Ltd, Preclin Res Dept, Haifa, Israel
[2] Novocure Ltd, Haifa, Israel
[3] Novocure GmbH, Luzern, Switzerland
来源：
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2017年 / 123期
关键词：
Cancer Research; Issue; 123; Tumor Treating Fields; TTFields; inovitro; glioma; ovarian cancer; frequency scan; ALTERNATING ELECTRIC-FIELDS; PHYSICIANS CHOICE CHEMOTHERAPY; IN-VITRO; LUNG-CANCER; COMBINATION; DISRUPTION; VIVO; GLIOBLASTOMA; THERAPY; SYSTEM;
D O I：
10.3791/55820
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Tumor Treating Fields (TTFields) are an effective treatment modality delivered via the continuous, noninvasive application of low-intensity (1-3 V/cm), alternating electric fields in the frequency range of several hundred kHz. The study of TTFields in tissue culture is carried out using the TTFields in vitro application system, which allows for the application of electric fields of varying frequencies and intensities to ceramic Petri dishes with a high dielectric constant (epsilon > 5,000). Cancerous cell lines plated on coverslips at the bottom of the ceramic Petri dishes are subjected to TTFields delivered in two orthogonal directions at various frequencies to facilitate treatment outcome tests, such as cell counts and clonogenic assays. The results presented in this report demonstrate that the optimal frequency of the TTFields with respect to both cell counts and clonogenic assays is 200 kHz for both ovarian and glioma cells.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells
    Strack, Maren
    Kueckelhaus, Jan
    Diebold, Martin
    Wuchter, Patrick
    Huber, Peter E.
    Schnell, Oliver
    Sankowski, Roman
    Prinz, Marco
    Grosu, Anca-Ligia
    Heiland, Dieter Henrik
    Nicolay, Nils H.
    Ruehle, Alexander
    JOURNAL OF NEURO-ONCOLOGY, 2024, 169 (02) : 329 - 340
  • [2] In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
    Blatt, Roni
    Davidi, Shiri
    Munster, Mijal
    Shteingauz, Anna
    Cahal, Shay
    Zeidan, Adel
    Marciano, Tal
    Bomzon, Zeev
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Kinzel, Adrian
    Palti, Yoram
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Using Computational Phantoms to Improve Delivery of Tumor Treating Fields (TTFields) to Patients
    Bomzon, Ze'ev
    Hershkovich, Hadas Sara
    Urman, Noa
    Chaudhry, Aafia
    Garcia-Carracedo, Dario
    Korshoej, Anders R.
    Weinberg, Uri
    Wenger, Cornelia
    Miranda, Pedro
    Wasserman, Yoram
    Kirson, Eilon D.
    Yoram
    2016 38TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2016, : 6461 - 6464
  • [4] Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
    Giladi, Moshe
    Munster, Mijal
    Schneiderman, Rosa S.
    Voloshin, Tali
    Porat, Yaara
    Blat, Roni
    Zielinska-Chomej, Katarzyna
    Haag, Petra
    Bomzon, Ze'ev
    Kirson, Eilon D.
    Weinberg, Uri
    Viktorsson, Kristina
    Lewensohn, Rolf
    Palti, Yoram
    RADIATION ONCOLOGY, 2017, 12
  • [5] Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
    Vergote, Ignace
    Macarulla, Teresa
    Hirsch, Fred R.
    Hagemann, Carsten
    Miller, David Scott
    CANCERS, 2023, 15 (03)
  • [6] Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment
    Wang, Minjie
    Zhang, Chaocai
    Wang, Xuan
    Yu, Hao
    Zhang, Hemei
    Xu, Junnv
    Zhao, Jiannong
    Jiang, Xiaobing
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (04): : 1069 - 1086
  • [7] The therapeutic efficacy and application prospects of tumor-treating fields (TTFields) in resolving malignant tumors of central nervous system
    Han, Wei
    Chen, Liang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [8] Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma
    Khagi, Simon
    Kotecha, Rupesh
    Gatson, Na Tosha N.
    Jeyapalan, Suriya
    Abdullah, Huda Ismail
    Avgeropoulos, Nicholas G.
    Batzianouli, Eleni T.
    Giladi, Moshe
    Lustgarten, Leonardo
    Goldlust, Samuel A.
    ONCOLOGIST, 2024,
  • [9] The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
    Oberheim-Bush, Nancy Ann
    Shi, Wenyin
    McDermott, Michael W.
    Grote, Alexander
    Stindl, Julia
    Lustgarten, Leonardo
    JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (03) : 453 - 461
  • [10] Tumor Treating Fields (TTFields) Therapy and Lomustine Chemotherapy for the Treatment of Unresectable Progressive Glioblastoma
    Mergen, Ertan
    Landrock, Sonja
    Chizzali, Barbara
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 1056 - 1062
12345